Author:
Abrencillo Rodeo,Mira-Avendano Isabel C.,Estrada-Y-Martin Rosa M.,Sadovnikov Irina,Zuchowski Colin,Kuyumcu Gokhan,Taneja Anjali,Duhancioglu Gabriel,Jayagurunathan Usha,LeComte Matthew,Palacio Diana,Hershman Michelle,de Groot Patricia M.,Truong Mylene T.,Moran Cesar A.
Publisher
Springer International Publishing
Reference433 articles.
1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161(2 Pt 1):646–64.
2. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.
3. Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941–52.
4. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994;150(4):967–72.
5. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006;61(11):980–5.